| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017885 |
| Receipt No. | R000020383 |
| Official scientific title of the study | Relationship between ambulatory blood pressure monitoring and renal tissue injury |
| Date of disclosure of the study information | 2015/06/12 |
| Last modified on | 2016/06/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Relationship between ambulatory blood pressure monitoring and renal tissue injury | |
| Title of the study (Brief title) | ABPM and renal tissue damage | |
| Region |
|
|
| Condition | ||
| Condition | glomerulonephritis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Hypertension is a common complication in chronic kidney disease patients. However, the influence of patterns of HT on renal tissue damage remains unclear. |
| Basic objectives2 | Others |
| Basic objectives -Others | We investigate the relationship between ambulatory blood pressure monitoring and renal tissue injury in glomerulonephritis. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Renal tissue damage(glomerulosclerosis, interstitial fibrosis, intminal thickening of intra-lobular arteries, artriolar hyalinosis) |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | over 16 years old
patients with 24hr ABPM |
|||
| Key exclusion criteria | patients who reject joining this study | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Nishi Shinichi |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Nephrology |
| Address | Kusunoki-cho 7-5-2, Chuou-ku, Kobe city |
| TEL | 078-382-6500 |
| snishi@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Kono Keiji |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Nephrology |
| Address | Kusunoki-cho 7-5-2, Chuou-ku, Kobe city |
| TEL | 078-382-6500 |
| Homepage URL | |
| kkono@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Kobe university graduate school of medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Kobe university graduate school of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 神戸大学病院、明石医療センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Retrospective observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020383 |